Stanford Cancer Institute is a clinical research site located in Palo Alto, California, United States 94304.
Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.
Stanford Cancer Institute has participated in 81 clinical trials with 36 currently active.
Therapeutic areas: mCRPC, Breast Cancer, Unresectable Head and Neck Squamous Cell Carcinoma.
Sponsors: Pfizer, Alliance for Clinical Trials in Oncology, BioNTech SE.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Palo Alto
Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford Cancer Institute has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford Cancer Institute has 81 clinical trials on record, with 36 currently active. Their work covers mCRPC, Breast Cancer, Unresectable Head and Neck Squamous Cell Carcinoma.
Stanford Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.